- Home
- BFRI vs VINC Comparison
BFRI vs VINC Comparison
Compare BFRI & VINC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFRI
- VINC
- Stock Information
- Founded
- BFRI 1997
- VINC 2019
- Country
- BFRI United States
- VINC United States
- Employees
- BFRI N/A
- VINC N/A
- Industry
- BFRI Biotechnology: Pharmaceutical Preparations
- VINC Biotechnology: Pharmaceutical Preparations
- Sector
- BFRI Health Care
- VINC Health Care
- Exchange
- BFRI Nasdaq
- VINC Nasdaq
- Market Cap
- BFRI 6.2M
- VINC 6.2M
- IPO Year
- BFRI 2021
- VINC N/A
- Fundamental
- Price
- BFRI $1.11
- VINC $1.24
- Analyst Decision
- BFRI Strong Buy
- VINC Buy
- Analyst Count
- BFRI 1
- VINC 2
- Target Price
- BFRI $7.00
- VINC $40.00
- AVG Volume (30 Days)
- BFRI 158.3K
- VINC 1.1M
- Earning Date
- BFRI 03-14-2025
- VINC 03-28-2025
- Dividend Yield
- BFRI N/A
- VINC N/A
- EPS Growth
- BFRI N/A
- VINC N/A
- EPS
- BFRI N/A
- VINC N/A
- Revenue
- BFRI $35,358,000.00
- VINC N/A
- Revenue This Year
- BFRI $17.69
- VINC N/A
- Revenue Next Year
- BFRI $19.71
- VINC N/A
- P/E Ratio
- BFRI N/A
- VINC N/A
- Revenue Growth
- BFRI 5.17
- VINC N/A
- 52 Week Low
- BFRI $0.65
- VINC $1.18
- 52 Week High
- BFRI $2.43
- VINC $187.44
- Technical
- Relative Strength Index (RSI)
- BFRI 49.87
- VINC 28.95
- Support Level
- BFRI $1.06
- VINC $1.18
- Resistance Level
- BFRI $1.16
- VINC $1.38
- Average True Range (ATR)
- BFRI 0.07
- VINC 0.11
- MACD
- BFRI -0.00
- VINC 0.09
- Stochastic Oscillator
- BFRI 55.00
- VINC 12.50
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.
About VINC Vincerx Pharma Inc.
Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are conducted in the United States. It focuses on developing, using, manufacturing, commercializing, sublicensing, and distributing a clinical-stage and follow-on small molecule drug program and a preclinical-stage bioconjugation/next-generation ADC platform.